Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies

Recently identified broadly neutralizing antibodies (bNAbs) that potently neutralize most HIV-1 strains are key to potential antibody-based therapeutic approaches to combat HIV/AIDS in the absence of an effective vaccine. Increasing bNAb potencies and resistance to common routes of HIV-1 escape thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Diskin, Ron, Klein, Florian, Horwitz, Joshua A., Halper-Stromberg, Ariel, Sather, D. Noah, Marcovecchio, Paola M., Lee, Terri, West, Anthony P., Gao, Han, Seaman, Michael S., Stamatatos, Leonidas, Nussenzweig, Michel C., Bjorkman, Pamela J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674693/
https://www.ncbi.nlm.nih.gov/pubmed/23712429
http://dx.doi.org/10.1084/jem.20130221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674693/
https://www.ncbi.nlm.nih.gov/pubmed/23712429
http://dx.doi.org/10.1084/jem.20130221

Ejemplares similares